Open AccessPrimary outcomes by 1q21+ status for isatuximab-treated patients with relapsed/refractory multiple myeloma: subgroup analyses from ICARIA-MM and IKEMA
Author(s) -
Tom Martin,
Paul G. Richardson,
Thierry Façon,
Philippe Moreau,
Aurore Perrot,
Ivan Špıčka,
Kamlesh Bisht,
Marlène Inchauspé,
France Casca,
Sandrine Macé,
Helgi van de Velde,
Kenshi Suzuki
Publication year - 2022
Publication title -
haematologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.782
H-Index - 142
eISSN - 1592-8721
pISSN - 0390-6078
DOI - 10.3324/haematol.2022.280660
Subject(s) - multiple myeloma , medicine , refractory (planetary science) , oncology , family medicine , psychology , biology , astrobiology